Tirzepatide (Zepbound and Mounjaro): weekly vials you load into a syringe yourself or preloaded injection pens Semaglutide (Wegovy and Ozempic): weekly, preloaded injection pen in various doses Liraglutide (Saxenda and Victoza): daily injectable pens Other GLP-1s and weight-loss meds: Trulicity , a less common GLP-1 (dulaglutide), comes in the form of a pen for once-weekly injections Bydureon BCise (once-weekly preloaded injection) Rybelsus (oral method) Contrave and Xenical (weight-loss drugs that are not GLP-1s and typically come at a much cheaper price tag) Other medications: antibiotics, antidepressants, asthma medication, and much, much more Note: Ozempic, Mounjaro, Victoza, Trulicity, Bydureon, and Rybelsus are FDA approved for type 2 diabetes only and must be prescribed off-label for use as a weight-loss treatment

Comparative effectiveness of glucagon-like peptide-1 agonists, dipeptidyl peptidase-4 inhibitors, and sulfonylureas on the risk of dementia in older individuals with type 2 diabetes in Sweden: an emulated trial study Tang, Bowen et al
What is Glutathione, and how does it help with skin brightening
The SELECT cardiovascular outcomes trial further demonstrated a 20% reduction in major cardiovascular events in patients with obesity and prior cardiovascular disease
Voigt, N
123 The results will allow to decide whether the CV protection by SGLT-2 inhibitors could be extended to all patients at risk of CVD (both in primary and secondary prevention) and whether the awaited findings with dapagliflozin support a class effect without significant heterogeneity